These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


273 related items for PubMed ID: 3454501

  • 1. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
    Negri P, Agnello G, Borghesani F, Tomain L, Minisci N, D'Errico G, Cavallini AR.
    Acta Eur Fertil; 1987; 18(6):375-80. PubMed ID: 3454501
    [Abstract] [Full Text] [Related]

  • 2. [Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel].
    Negri P, D'Errico G, Minisci N, Tomasi A.
    Minerva Ginecol; 1988 Dec; 40(12):699-707. PubMed ID: 2977429
    [Abstract] [Full Text] [Related]

  • 3. An open study of Triphasil and Diane 50 in the treatment of acne.
    Wishart JM.
    Australas J Dermatol; 1991 Dec; 32(1):51-4. PubMed ID: 1834045
    [Abstract] [Full Text] [Related]

  • 4. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Dec; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Dec; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A, Dewailly SD, Grenier R, Huard J.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [Abstract] [Full Text] [Related]

  • 7. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 8. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R, Hirvensalo E, Liukko P, Malmiharju T, Mattila L, Riihiluoma P, Ylöstalo P.
    Acta Derm Venereol; 1984 Aug; 64(6):517-23. PubMed ID: 6084924
    [Abstract] [Full Text] [Related]

  • 9. Short-term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1989 Aug; 20(1):35-7. PubMed ID: 2528880
    [Abstract] [Full Text] [Related]

  • 10. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R.
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [Abstract] [Full Text] [Related]

  • 11. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

  • 12. The relevance of the pharmacologic properties of a progestational agent to its clinical effects as a combination oral contraceptive.
    Upton GV, Corbin A.
    Yale J Biol Med; 1989 Jun; 62(5):445-57. PubMed ID: 2534253
    [Abstract] [Full Text] [Related]

  • 13. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
    De Leo V, Di Sabatino A, Musacchio MC, Morgante G, Scolaro V, Cianci A, Petraglia F.
    Contraception; 2010 Sep; 82(3):276-80. PubMed ID: 20705157
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    Coenen CM, Thomas CM, Borm GF, Rolland R.
    Int J Fertil Menopausal Stud; 1995 Sep; 40 Suppl 2():92-7. PubMed ID: 8574256
    [Abstract] [Full Text] [Related]

  • 15. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
    Mango D, Ricci S, Manna P, Miggiano GA, Serra GB.
    Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

  • 17. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W.
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [Abstract] [Full Text] [Related]

  • 18. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P, Lähteenmäki P, Rutanen EM.
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [Abstract] [Full Text] [Related]

  • 19. Effect of low-dose oral contraceptives on androgenic markers and acne.
    Thorneycroft IH, Stanczyk FZ, Bradshaw KD, Ballagh SA, Nichols M, Weber ME.
    Contraception; 1999 Nov; 60(5):255-62. PubMed ID: 10717776
    [Abstract] [Full Text] [Related]

  • 20. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C, Thaipisuttikul Y, Pinjaroen S, Krisanapan O, Benjawang W, Koster A, Doesburg W.
    Int J Fertil Menopausal Stud; 1996 Nov; 41(4):423-9. PubMed ID: 8894800
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.